Optical monitoring and treatment of potentially lethal wound infections in vivo

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1717-1725

  Hamblin, Michael R ^a,b   Zahra, Touqir ^a,b,e   Contag, Christopher H ^c   McManus, Albert T ^d   Hasan, Tayyaba ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Institute of Surgical Research   (United States)

^e NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; POLYCATION; POLYLYSINE; SILVER NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BIOLUMINESCENCE; CAMERA; CELL INVASION; CONTROLLED STUDY; DEATH; DEVICE; DISEASE MODEL; DOSE RESPONSE; DRUG CONJUGATION; DRUG DESIGN; GRAM NEGATIVE INFECTION; ILLUMINATION; IMAGE ANALYSIS; IMAGING; IN VIVO STUDY; INHIBITION KINETICS; LETHALITY; MALE; MEASUREMENT; MONITORING; MOUSE; NONHUMAN; OPERON; OPTICS; PHOTODYNAMIC THERAPY; PHOTOLUMINESCENCE; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RADIATION DOSE; RED LIGHT; STIMULATION; SURVIVAL; SURVIVAL RATE; TECHNIQUE; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; LIGHT; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; POLYLYSINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKIN; TIME FACTORS; WOUND HEALING; WOUND INFECTION;

EID: 0037526590     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375244     Document Type: Article

References (32)

1. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90:889-905.
2. Daniell MD, Hill JS. A history of photodynamic therapy. Aust N Z J Surg 1991; 61:340-8.
3. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998; 42:13-28.
4. Soukos NS, Ximenez-Fyvie LA, Hamblin MR, Socransky SS, Hasan T. Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother 1998; 42:2595-601.
5. Hamblin MR, O'Donnell DA, Murthy N, Contag CH, Hasan T. Photodynamic treatment of wound infections in vivo monitored by luminescence imaging. Photochem Photobiol 2002; 75:51-7.
6. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 1995; 18:593-603.
7. Rocchetta HL, Boylan CJ, Foley JW, et al. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother 2001; 45:129-37.
8. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 2000; 68:3594-600.
9. Van Delden C, Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998; 4:551-60.
10. Gordon SM, Serkey JM, Keys TF, et al. Secular trends in nosocomial bloodstream infections in a 55-bed cardiothoracic intensive care unit. Ann Thorac Surg 1998; 65:95-100.
11. Bergen GA, Shelhamer JH. Pulmonary infiltrates in the cancer patient. New approaches to an old problem. Infect Dis Clin North Am 1996; 10:297-325.
12. Fergie JE, Shema SJ, Lott L, Crawford R, Patrick CC. Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome. Clin Infect Dis 1994; 18:390-4.
13. Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richer H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994; 170:377-83.
14. Hirosue M, Maeda H, Miyamoto M, Takashiba S, Murayama Y, Chart H. An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha, and EQ1. Res Microbiol 2000; 151:721-5.
15. Milligan RC, Rust J, Rosenthal SM. Gamma globulin factors protective against infections from Pseudomonas and other organisms. Science 1957; 126:509-11.
16. Rosenthal SM. Local and systemic therapy of pseudomonas septicemia in burned mice. Ann Surg 1967; 165:97-103.
17. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify, protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87:206-10.
18. Jett BD, Hatter KL, Huycke MM, Gilmore MS. Simplified agar plate method for quantifying viable bacteria. Biotechniques 1997; 23:648-50.
19. Siragusa GR, Nawotka K, Spilman SD, Contag PR, Contag CH. Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter. Appl Environ Microbiol 1999; 65:1738-45.
20. Hancock RE. The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it. Antibiot Chemother 1985; 36:95-102.
21. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 1997; 39:1-18.
22. Berthiaume F, Reiken SR, Toner M, Tompkins RG, Yarmush ML. Antibody-targeted photolysis of bacteria in vivo. Biotechnology 1994; 12:703-6.
23. Lombard GF, Tealdi S, Lanotte MM. The treatment of neurosurgical infections by lasers and porphyrins. In: Jori G, Perria CA, eds. Photodynamic therapy of tumors and other diseases. Padova, Italy: Edizione Libreria Progetto, 1985:363-6.
24. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93:155-60.
25. Wilder-Smith CH, Wilder-Smith P, Grosjean P, et al. Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg Med 2002; 31:18-22.
26. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000; 2:1051-60.
27. Goldberg JB, Coyne MJ Jr, Neely AN, Holder IA. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect Immun 1995; 63:4166-9.
28. Holder IA, Neely AN, Frank DW. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect Immun 2001; 69:5908-10.
29. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998; 22:135-45.
30. Wretlind B, Pavlovskis OR. Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis 1983; 5(suppl 5):S998-1004.
31. Komerik N, Wilson M, Poole S. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol 2000; 72:676-80.
32. Monafo WW, West MA. Current treatment recommendations for top-ical burn therapy. Drugs 1990; 40:364-73.